Diabetes Insights - Breakthroughs and Innovators

EASD presents: Diabetes Insights - Breakthroughs and Innovators

Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management.

Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes.

These podcasts were recorded at an EASD Annual Meeting. You can learn more about the research discussed by watching the scientific presentations in the EASD Media Centre (https://www.easd.org/media-centre/).

New episode released every Friday.

Diabetes Insights - Breakthroughs and Innovators

Latest episodes

Introducing the EASD-EFSD Rising Stars 2026

More episodes

All episodes
15 min

What's Happened Since New Orleans?

What are the implications of the ongoing dispute involving the American Diabetes Association for scientific independence and the wider diabetes research community?

In this EASD TV conversation, host Vivienne Parry speaks with Prof. John Buse and Prof. Steve Kahn about the events surrounding the ADA Scientific Sessions in New Orleans and the developments that followed. They discuss the Diabetes Care editorial team's boycott, questions of editorial independence and transparency, and the importance of member representation and scientific voices within professional organisations.

10 min

Pre-Diabetes Remission to Prevention of Type 2 Diabetes

In this episode, EASD TV host Vivienne Parry speaks with Prof. Andreas Birkenfeld, recipient of the 2026 Camillo Golgi Prize, about the importance of preventing type 2 diabetes and its complications.

The conversation explores the concept of pre-diabetes remission as a potential target for prevention, the need for earlier detection and the role of lifestyle interventions. Prof. Birkenfeld discusses how improvements in diet and physical activity can support metabolic health, including the potential benefits of fibre and unsaturated fatty acids beyond weight loss alone.

They also consider the challenges of raising awareness, expanding screening and helping people at risk make...

17 min

The Story of GLP-1 Receptor Agonists

How did decades of research into gut hormones lead to GLP-1-based treatments for type 2 diabetes and obesity?

In this EASD TV conversation, host Vivienne Parry speaks with Prof. Jens Juul Holst, recipient of the 2nd Global Impact Prize, about the early discoveries behind GLP-1, the development of effective therapies and their wider metabolic and cardiovascular effects.

He also discusses global access and affordability, the challenges of counterfeit medicines, and why fundamental research continues to shape the future of diabetes treatment.

7 min

Unlocking Energy Expenditure for Cardiometabolic Therapies

In this EASD TV interview, Prof. Zachary Gerhart-Hines (Novo Nordisk Foundation Center for Basic Metabolic Research), 61st EASD Minkowski Prize recipient, discusses research into the neurokinin-2 receptor (NK2R) and its potential to change how we approach weight management and metabolic health. Where many existing treatments focus on reducing food intake, NK2R activation could offer a complementary strategy by increasing energy expenditure, influencing appetite and improving insulin sensitivity.

The conversation explores why the quality of weight loss matters and why this could be important for older adults. Prof. Gerhart-Hines also explains how the pathway’s unexpected connections between fat tissue, the brain...